InvestorsHub Logo

Brian903

07/27/19 10:27 AM

#97073 RE: oldmusky #97072

Nice one Musky!!! Made me chuckle..

1234jklm

07/27/19 10:57 AM

#97074 RE: oldmusky #97072

Thankyou musky.

So sad to see the company promoted on this big biz level when it has so much to offer and is part of the future of medicine.

It says a lot about the mentality and vision that some have for Pharmacyte and you deserve thanks for calling on it.

mwebb1514

07/27/19 11:07 AM

#97075 RE: oldmusky #97072

I might be reading the article wrong but I don’t think PharmaCyte was the author. The comparison wasn’t too favorable to our little company and seems like a warning to potential investors.

But as a business model, I would be tickled to see PharmaCyte attain the level of success Amgen has over the last forty years (but, I don’t think I’ll live that long). Amgen started as a penny stock and has grown to see $200 a share (with half as many outstanding shares), and pays dividends!

That would be quite a model for PharmaCyte to follow! Hope it takes significantly less than 40 years. :-D

A2Z

07/27/19 11:13 AM

#97077 RE: oldmusky #97072

Good post oldmusky. I for one am most certainly concern now more than usual. You know we all here have our big boy and big girl pants on and handle the truth whether good or bad. Why this ceo keeps playing In the penny stock mentality league is beyond me. This company can really go to new heights. But it’s obvious not until with new management.